Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    12200674 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse
Condition: Leukemia
Interventions: Drug: chemotherapy;   Drug: gemtuzumab ozogamicin

Indicates status has not been verified in more than two years